Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

9.0K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial.

Brain communications·2026
Same author

Peri-ictal magnetic resonance imaging findings in pediatric seizures: a scoping review on pearls and pitfalls from a heterogeneous population.

Translational pediatrics·2026
Same author

Challenges and future directions for multiple sclerosis after the 2024 McDonald diagnostic criteria.

Nature medicine·2026
Same author

Reduced cortical gyrification in type 1 diabetes is associated with white matter integrity loss and cognitive decline.

Metabolic brain disease·2026
Same author

Comprehensive Structural MRI Phenotyping in <i>Oligophrenin 1-</i>Related Disorder Reveals Characteristic Brain Malformations.

AJNR. American journal of neuroradiology·2026
Same author

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Health technology assessment (Winchester, England)·2026

Related Experiment Video

Updated: Jan 12, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K

Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy.

Riccardo Nistri1,2, Ermelinda De Meo1, Nee Na Kim1,2

  • 1Queen Square MS Center, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, United Kingdom.

Neurology(R) Neuroimmunology & Neuroinflammation
|November 3, 2025
PubMed
Summary

Paramagnetic rim lesions (PRLs) are common in pediatric multiple sclerosis (MS), indicating active inflammation. Higher PRL counts correlate with increased lesion burden and gray matter atrophy in children with MS.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.9K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.4K

Related Experiment Videos

Last Updated: Jan 12, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.9K
Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

4.4K

Area of Science:

  • Neuroimaging
  • Pediatric Neurology
  • Inflammatory Diseases

Background:

  • Paramagnetic rim lesions (PRLs) on susceptibility-based imaging (SbI) signify chronic active inflammation in multiple sclerosis (MS).
  • In adult MS, PRLs are linked to a more aggressive disease course.
  • The prevalence and significance of PRLs in pediatric MS remain less understood.

Purpose of the Study:

  • To determine the prevalence of PRLs in children diagnosed with MS.
  • To investigate the association between baseline PRL count and clinical disability.
  • To examine the relationship between baseline PRL count and brain tissue volume loss, both cross-sectionally and over short-term follow-up.

Main Methods:

  • Retrospective analysis of pediatric MS patients from UK neuroimmunology centers.
  • MRI data including SbI were analyzed to identify and classify PRLs.
  • Brain volumes were segmented, and associations with PRL burden, clinical variables, and longitudinal changes were assessed using regression models.

Main Results:

  • 74.1% of pediatric MS patients had at least one PRL, with a median of 2.
  • Higher PRL counts were associated with greater T2-hyperintense lesion burden.
  • Increased PRL count correlated with lower gray matter volume z-scores and predicted greater deep gray matter volume loss over 17 months.

Conclusions:

  • PRLs are prevalent in pediatric MS and indicate significant brain tissue damage, including gray matter atrophy.
  • PRLs may serve as valuable imaging biomarkers for disease severity in pediatric MS.
  • Further long-term studies are needed to confirm the predictive ability of PRLs for future disability in pediatric MS.